Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 2021 Jun 25;70(10):3055. doi: 10.1007/s00262-021-02977-6

Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A*02:01‑restricted T cell epitopes, which are presented and recognized in vivo

Anja Tatjana Teck 1, Sabrina Urban 1, Petra Quass 1,2,7, Annika Nelde 3,4, Heiko Schuster 3,5, Anne Letsch 1,7, Antonia Busse 1,7, Juliane Sarah Walz 6,7, Ulrich Keilholz 2,7, Sebastian Ochsenreither 1,2,7,
PMCID: PMC8423697  PMID: 34170381

Correction to: Cancer Immunology, Immunotherapy (2020) 69:1217–1227 10.1007/s00262-020-02519-6

The article Cancer testis antigen Cyclin A1 harbors several HLA‑A*02:01‑restricted T cell epitopes, which are presented and recognized in vivo, written by Anja Tatjana Teck, Sabrina Urban, Petra Quass, Annika Nelde, Heiko Schuster, Anne Letsch, Antonia Busse, Juliane Sarah Walz, Ulrich Keilholz and Sebastian Ochsenreither, was originally published Online First without Open Access. After publication in volume 69, issue 7, page 1217–1227 the author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2021 and this article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

The original article has been corrected.

Funding

Open Access funding enabled and organized by Projekt DEAL.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES